U.S. President Donald Trump has pledged to help “Dilbert” creator Scott Adams receive treatment for his metastatic prostate cancer after the cartoonist appealed directly to him on social media. Adams, who is battling advanced prostate cancer, posted on X that he was struggling to schedule his treatment with the targeted radiotherapy drug Pluvicto, despite approval from his healthcare provider, Kaiser Permanente of Northern California. “I am declining fast,” Adams wrote. “Pluvicto will give me a fighting chance to stick around on this planet a little bit longer.”
Trump quickly responded, posting, “On it,” signaling his intent to intervene. Health and Human Services Secretary Robert F. Kennedy also commented online, writing, “The President wants to help.”
Kaiser Permanente later stated that Adams’ oncology team “is working closely with him on the next steps in his cancer care, which are already underway.” The organization emphasized that since Pluvicto’s approval, it has treated more than 150 Northern California patients with the same drug, adding, “We know this drug and this disease.”
Pluvicto, developed by Swiss pharmaceutical company Novartis, has been shown to reduce the risk of progression or death in prostate cancer patients by 28%. The therapy combines tumor-targeting molecules with radioactive particles that kill cancer cells.
Adams gained fame in 1989 with the launch of Dilbert, one of America’s most popular workplace comic strips. However, his career took a major hit in 2023 when numerous newspapers dropped the comic following Adams’ controversial remarks labeling Black Americans a “hate group.” He later said his comments were hyperbolic and taken out of context.
Trump’s public support for Adams underscores the intersection of celebrity, politics, and healthcare in the social media era — and highlights growing attention on access to advanced cancer treatments.